Literature DB >> 22038263

The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice.

Yoko Fujiwara1, Akito Tanoue, Gozoh Tsujimoto, Taka-Aki Koshimizu.   

Abstract

A prompt rise in blood pressure occurs when arginine-vasopressin is administered in quantities adequate to activate vascular V1a subtype vasopressin receptors. However, it has been controversial whether the endogenous vasopressin-V1a system contributes to the maintenance of basal blood pressure during normal development and aging. Mutant mice lacking the V1a receptor gene (V1a(-/-)) show significantly lower blood pressure compared to control mice, without a notable change in heart rate. In V1a(-/-) mice, arterial baroreceptor reflexes were attenuated due to malfunctioning baroreflex center, and the mice's circulating blood volume was significantly reduced. In line with this reduction in circulating blood volume, adrenocortical hormone release was attenuated; plasma aldosterone levels were reduced and adrenocorticotropic hormone-stimulated corticosteroid release was attenuated. In addition, V1a receptor expression was detected in macula densa cells of the kidneys, which may have facilitated renin production from the juxtaglomerular cells. Deletion of the V1a receptor appears to impact the renin-angiotensin-aldosterone system. Studies on V1a(-/-) mice revealed that non-vascular V1a receptors in the central nervous system and peripheral tissues play critical roles in the maintenance of blood pressure homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038263     DOI: 10.1007/s10157-011-0497-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  43 in total

Review 1.  Molecular pharmacology and modeling of vasopressin receptors.

Authors:  M Thibonnier; P Coles; A Thibonnier; M Shoham
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

2.  Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin.

Authors:  C Rivier; W Vale
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

3.  Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures.

Authors:  G L Kovács; B Bohus; D H Versteeg; E R de Kloet; D de Wied
Journal:  Brain Res       Date:  1979-10-19       Impact factor: 3.252

4.  Expression of vasopressin V1a and V2 receptor messenger ribonucleic acid in the liver and kidney of embryonic, developing, and adult rats.

Authors:  N L Ostrowski; W S Young; M A Knepper; S J Lolait
Journal:  Endocrinology       Date:  1993-10       Impact factor: 4.736

5.  Prostaglandins and renin release: the effect of PGI2, PGE2, and 13,14-dihydro PGE2 on the baroreceptor mechanism of renin release in the dog.

Authors:  J G Gerber; R T Keller; A S Nies
Journal:  Circ Res       Date:  1979-06       Impact factor: 17.367

6.  AVP-induced activation of MAP kinase in vascular smooth muscle cells is mediated through protein kinase C.

Authors:  A Kribben; E D Wieder; X Li; V van Putten; Y Granot; R W Schrier; R A Nemenoff
Journal:  Am J Physiol       Date:  1993-10

Review 7.  Vasopressin in cardiovascular control: role of circulating vasopressin.

Authors:  J F Liard
Journal:  Clin Sci (Lond)       Date:  1984-11       Impact factor: 6.124

8.  Tolvaptan.

Authors:  Jalal K Ghali; Bashar Hamad; Uma Yasothan; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2009-08       Impact factor: 84.694

Review 9.  Vasopressin in circulatory control and hypertension.

Authors:  C I Johnston
Journal:  J Hypertens       Date:  1985-12       Impact factor: 4.844

10.  Impaired arginine-vasopressin-induced aldosterone release from adrenal gland cells in mice lacking the vasopressin V1A receptor.

Authors:  Jun-ichi Birumachi; Masami Hiroyama; Yoko Fujiwara; Toshinori Aoyagi; Atsushi Sanbe; Akito Tanoue
Journal:  Eur J Pharmacol       Date:  2007-03-24       Impact factor: 4.432

View more
  11 in total

1.  Conformation and dynamics of 8-Arg-vasopressin in solution.

Authors:  Elke Haensele; Lee Banting; David C Whitley; Timothy Clark
Journal:  J Mol Model       Date:  2014-11-06       Impact factor: 1.810

2.  High salt intake increases blood pressure via BDNF-mediated downregulation of KCC2 and impaired baroreflex inhibition of vasopressin neurons.

Authors:  Katrina Y Choe; Su Y Han; Perrine Gaub; Brent Shell; Daniel L Voisin; Blayne A Knapp; Philip A Barker; Colin H Brown; J Thomas Cunningham; Charles W Bourque
Journal:  Neuron       Date:  2015-01-22       Impact factor: 17.173

3.  Evidence for a Prehypertensive Water Dysregulation Affecting the Development of Hypertension: Results of Very Early Treatment of Vasopressin V1 and V2 Antagonism in Spontaneously Hypertensive Rats.

Authors:  Ignazio Verzicco; Stefano Tedeschi; Gallia Graiani; Alice Bongrani; Maria Luisa Carnevali; Simona Dancelli; Jessica Zappa; Silvia Mattei; Achiropita Bovino; Stefania Cavazzini; Rossana Rocco; Anna Calvi; Barbara Palladini; Riccardo Volpi; Valentina Cannone; Pietro Coghi; Alberico Borghetti; Aderville Cabassi
Journal:  Front Cardiovasc Med       Date:  2022-06-01

4.  Evidence for involvement of central vasopressin V1b and V2 receptors in stress-induced baroreflex desensitization.

Authors:  Sanja Milutinović-Smiljanić; Olivera Šarenac; Maja Lozić-Djurić; David Murphy; Nina Japundžić-Žigon
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

5.  Decreased expression of aquaporin 2 in the collecting duct of mice lacking the vasopressin V1a receptor.

Authors:  Yukiko Yasuoka; Mizuka Kobayashi; Yuichi Sato; Hiroshi Nonoguchi; Akito Tanoue; Hirotsugu Okamoto; Katsumasa Kawahara
Journal:  Clin Exp Nephrol       Date:  2012-09-12       Impact factor: 2.801

Review 6.  Vasopressin, Central Autonomic Control and Blood Pressure Regulation.

Authors:  Maja Lozić; Olivera Šarenac; David Murphy; Nina Japundžić-Žigon
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

7.  Vasopressin and oxytocin in control of the cardiovascular system.

Authors:  Nina Japundžić-Žigon
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

8.  Effects of aqueous leaf extract of Asystasia gangetica on the blood pressure and heart rate in male spontaneously hypertensive Wistar rats.

Authors:  Pierre Mugabo; Ismaila A Raji
Journal:  BMC Complement Altern Med       Date:  2013-10-26       Impact factor: 3.659

9.  Effect of Chronic Kidney Disease on Changes in Vasopressin System Expression in the Kidney Cortex in Rats with Nephrectomy.

Authors:  Katarzyna Czarzasta; Agnieszka Cudnoch-Jedrzejewska; Longin Niemczyk; Robert Wrzesien; Marzanna Tkaczyk; Liana Puchalska; Marek Saracyn; Wawrzyniec Zmudzki; Stanisław Niemczyk
Journal:  Biomed Res Int       Date:  2018-06-14       Impact factor: 3.411

Review 10.  Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review.

Authors:  Nina Japundžić-Žigon; Maja Lozić; Olivera Šarenac; David Murphy
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.